The estrogen-related receptors (ERRs): potential targets against bone loss

Ling Zhang1,2, Jiemin Wong2, Jean-Marc Vanacker3

  • 1Institut de Génomique Fonctionnelle de Lyon, CNRS UMR5242, Université de Lyon, Université Lyon I, Ecole Normale Supérieure de Lyon, Lyon, France.

Insights

Estrogen-related receptors (ERRs) alpha and gamma hinder bone formation. Inhibiting these receptors offers a new anabolic strategy to combat bone loss and skeletal fragility, particularly in post-menopause women.

Area of Science:

  • Endocrinology
  • Bone Biology
  • Metabolic Diseases

Background:

  • Bone loss and skeletal fragility are significant health issues, often linked to aging and estrogen deficiency in post-menopausal women.
  • Current treatments primarily focus on inhibiting bone resorption, leaving a need for anabolic strategies that promote bone formation.

Purpose of the Study:

  • To investigate the role of estrogen-related receptors (ERRs) alpha and gamma in bone formation.
  • To explore the potential of inhibiting ERRs as an anabolic therapeutic approach for bone loss.

Main Methods:

  • Review and summarization of existing data on estrogen-related receptors (ERRs) alpha and gamma.
  • Analysis of the impact of ERRs on bone formation processes.

Main Results:

  • Data indicate that estrogen-related receptors (ERRs) alpha and gamma actively prevent bone formation.
  • This suggests a novel mechanism by which these receptors influence skeletal health.

Conclusions:

  • Inhibition of estrogen-related receptors (ERRs) alpha and gamma presents a promising anabolic strategy to increase bone formation.
  • Targeting ERRs could offer a new therapeutic avenue for treating bone loss and preventing skeletal fragility.

Related Concept Videos

Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.9K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
6.0K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.6K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.1K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
4.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.7K